Cargando…
The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246482/ https://www.ncbi.nlm.nih.gov/pubmed/37278148 http://dx.doi.org/10.1080/0886022X.2023.2220420 |
_version_ | 1785055038754783232 |
---|---|
author | Chen, Yunxian Zhou, Xiwen Chen, Zhixin Xia, Jue Guan, Fenglei Li, Yue Li, Yanrong Chen, Yicai Zhao, Yuanlin Qiu, Huayun Liang, Jiarong Tang, Liangqiu |
author_facet | Chen, Yunxian Zhou, Xiwen Chen, Zhixin Xia, Jue Guan, Fenglei Li, Yue Li, Yanrong Chen, Yicai Zhao, Yuanlin Qiu, Huayun Liang, Jiarong Tang, Liangqiu |
author_sort | Chen, Yunxian |
collection | PubMed |
description | Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking.Methods: We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve.Results: The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789–0.894) and 0.821 (95% CI: 0.760–0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03–9.86; p = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54–14.68; p = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02–8.24; p = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66–16.86, p = 0.005).Conclusions: Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD. |
format | Online Article Text |
id | pubmed-10246482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-102464822023-06-08 The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease Chen, Yunxian Zhou, Xiwen Chen, Zhixin Xia, Jue Guan, Fenglei Li, Yue Li, Yanrong Chen, Yicai Zhao, Yuanlin Qiu, Huayun Liang, Jiarong Tang, Liangqiu Ren Fail Research Article Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking.Methods: We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve.Results: The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789–0.894) and 0.821 (95% CI: 0.760–0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03–9.86; p = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54–14.68; p = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02–8.24; p = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66–16.86, p = 0.005).Conclusions: Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD. Taylor & Francis 2023-06-06 /pmc/articles/PMC10246482/ /pubmed/37278148 http://dx.doi.org/10.1080/0886022X.2023.2220420 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Article Chen, Yunxian Zhou, Xiwen Chen, Zhixin Xia, Jue Guan, Fenglei Li, Yue Li, Yanrong Chen, Yicai Zhao, Yuanlin Qiu, Huayun Liang, Jiarong Tang, Liangqiu The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title | The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title_full | The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title_fullStr | The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title_full_unstemmed | The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title_short | The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
title_sort | use of high-sensitivity cardiac troponin t and creatinine kinase-mb as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246482/ https://www.ncbi.nlm.nih.gov/pubmed/37278148 http://dx.doi.org/10.1080/0886022X.2023.2220420 |
work_keys_str_mv | AT chenyunxian theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT zhouxiwen theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT chenzhixin theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT xiajue theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT guanfenglei theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liyue theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liyanrong theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT chenyicai theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT zhaoyuanlin theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT qiuhuayun theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liangjiarong theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT tangliangqiu theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT chenyunxian useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT zhouxiwen useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT chenzhixin useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT xiajue useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT guanfenglei useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liyue useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liyanrong useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT chenyicai useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT zhaoyuanlin useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT qiuhuayun useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT liangjiarong useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease AT tangliangqiu useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease |